Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;44(5):281-288.
doi: 10.1016/j.acuro.2019.10.007. Epub 2020 Apr 10.

Empiric therapy for idiopathic oligoasthenoteratozoospermia

[Article in English, Spanish]
Affiliations
Review

Empiric therapy for idiopathic oligoasthenoteratozoospermia

[Article in English, Spanish]
R García-Baquero et al. Actas Urol Esp (Engl Ed). 2020 Jun.

Abstract

Male infertility accounts for 50% of the causes of infertile couples, being more than 30% of unknown etiology. In these cases, empiric treatment can be an option prior to the application of assisted reproduction techniques. Empiric treatment can be categorized as hormonal, such as gonadotropins, antiestrogens and aromatase inhibitors, and antioxidant, with vitamins, trace elements and carnitine, among others. Although scientifically acceptable evidence is limited due to the absence of large randomized and controlled clinical trials, recent systematic reviews and meta-analyses show that treatment with gonadotropins, antiestrogens and antioxidants increases pregnancy and live birth rates and improves seminal parameters. Empiric medical treatment for idiopathic infertility can be considered in specific cases in order to improve semen quality and spontaneous fertility.

Keywords: Empiric treatment; Idiopathic male infertility; Idiopathic oligoasthenoteratozoospermia; Infertilidad masculina idiopática; Oligoastenoteratozoospermia idiopática; Tratamiento empírico.

PubMed Disclaimer

Similar articles

Cited by

  • Antioxidants for male subfertility.
    de Ligny W, Smits RM, Mackenzie-Proctor R, Jordan V, Fleischer K, de Bruin JP, Showell MG. de Ligny W, et al. Cochrane Database Syst Rev. 2022 May 4;5(5):CD007411. doi: 10.1002/14651858.CD007411.pub5. Cochrane Database Syst Rev. 2022. PMID: 35506389 Free PMC article. Review.

LinkOut - more resources